Patents by Inventor Peter ACHENBACH

Peter ACHENBACH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12620489
    Abstract: The present invention relates to a method of determining whether a subject is at risk of developing type 1 diabetes by determining the genetic risk score (GRS) of a subject. The present invention also comprises a pharmaceutical composition comprising insulin and a pharmaceutical acceptable carrier for use in a method for preventing type 1 diabetes in a subject having a genetic risk score as determined by the method mentioned above. Further, it encompasses a kit for use in a method of determining whether a subject is at risk of developing type 1 diabetes by determining the genetic risk score of a subject and a type 1 diabetes antigen for use in a method of immunizing a subject against type 1 diabetes having a genetic risk score as determined by the method mentioned above.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: May 5, 2026
    Assignees: Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Technische Universität Dresden
    Inventors: Anette-G. Ziegler, Ezio Bonifacio, Christiane Winkler, Jan Krumsiek, Fabian Theis, Peter Achenbach
  • Publication number: 20200126671
    Abstract: The present invention relates to a method of determining whether a subject is at risk of developing type 1 diabetes by determining the genetic risk score (GRS) of a subject. The present invention also comprises a pharmaceutical composition comprising insulin and a pharmaceutical acceptable carrier for use in a method for preventing type 1 diabetes in a subject having a genetic risk score as determined by the method mentioned above. Further, it encompasses a kit for use in a method of determining whether a subject is at risk of developing type 1 diabetes by determining the genetic risk score of a subject and a type 1 diabetes antigen for use in a method of immunizing a subject against type 1 diabetes having a genetic risk score as determined by the method mentioned above.
    Type: Application
    Filed: June 27, 2018
    Publication date: April 23, 2020
    Inventors: Anette-G. ZIEGLER, Ezio BONIFACIO, Christiane WINKLER, Jan KRUMSIEK, Fabian THEIS, Peter ACHENBACH